Clinical Trial Results:
Multicenter, randomized, open label, controlled clinical trial that compares the efficacy of the combination of colistin and meropenem versus monotherapy for the treatment of bacteremia and pneumonia due to Pseudomonas aeruginosa extremely resistant with reduced sensitivity to meropenem
Summary
|
|
EudraCT number |
2013-005583-25 |
Trial protocol |
ES |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Sep 2022
|
First version publication date |
28 Sep 2022
|
Other versions |
|
Summary report(s) |
Publication of microbiology analysis and results Notification of premature end of the trial |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.